The independent source for health policy research, polling, and news.
181 - 200 of 458 Results
The FDA has approved a cannabis-derived drug, Epidiolex, to treat some forms of epilepsy. Now people who have other forms of the condition are using over-the-counter CBD products in hopes of taming their seizures. But doctors and patients worry about the unregulated world of CBD, in which product ingredients can be a mystery.
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the governments covid-fighting strategy.
The Supreme Courts decision overturning Roe v. Wade has created far more questions than it has answered about the continued legality and availability of abortion, as both abortion rights supporters and anti-abortion activists scramble to put their marks on policy. Meanwhile, Congress completes work on its gun bill and the FDA takes up the problem of the next covid-19 booster. Margot Sanger-Katz of The New York Times, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of KHN join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHNs Angela Hart, who reported and wrote the latest KHN-NPR Bill of the Month episode about two identical eye surgeries with very different price tags.
The FDA is using its power to regulate tobacco products ordering the vaping device Juul off the market and announcing its intention to lower the amount of nicotine in cigarettes and other products. Meanwhile, the Supreme Court rules on Medicare and kidney dialysis, and Congress makes progress on legislation surrounding guns and mental health. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHNs Noam N. Levey about the new KHN-NPR project on the growing impact of medical debt.
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a persons stomach, to help people eat less. Results vary widely but are modest on average.
As a Senate committee considered legislation to reauthorize the FDAs user fee program, Sens. Bernie Sanders and Rand Paul agreed on a proposed amendment related to importing drugs from Canada, the U.K., and other nations.
The wait is nearly over for parents of kids under 5 as a key advisory committee to the FDA recommends authorizing a covid-19 vaccine for the youngest children. Meanwhile, Congress is struggling to fill in the details of its gun control compromise, and, as the Supreme Court prepares to throw the question of abortion legality back to the states, the number of abortions has been rising. Shefali Luthra of The 19th, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KHNs Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
One million Americans have died from covid-19 far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nations pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicares trustees board.
At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the nations most popular emergency contraception brand rests in the unlikely stewardship of two private equity firms.
The Biden administration may have authority to allow the use of abortion pills even in states where the practice could be outlawed, say legal experts.
Two mass shootings in two weeks one at a Texas elementary school that killed 19 fourth graders and two teachers have reignited the guns-as-public-health-problem debate. But political consensus seems as far away as ever. Meanwhile, the FDA is in the congressional hot seat over its handling of the infant formula shortage. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KHN join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Richard Baron, head of the American Board of Internal Medicine, about how doctors should discipline colleagues who spread medical misinformation.
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
Cue got attention with a Super Bowl ad for a stylish high-tech covid-testing machine to use at home. But the product is expensive, which has limited the San Diego companys market.
The nations largest supplier of platelets is moving to a method it says is easier for hospitals, but one that sharply raises costs, leading some centers to demand more options.
After a leaked Supreme Court draft opinion was published May 2 suggesting that Roe v. Wade would soon be overturned, social media users started worrying that their use of period-tracking apps could lead to trouble if they sought an abortion and lived in a state with strict limits or bans on the procedure.
Covid cases are again climbing, but you wouldnt know it from the behavior of public health and elected officials, much less the general public, all of whom seem to want to put the pandemic in the rearview mirror. Meanwhile, the fallout over the leaked Supreme Court draft opinion on abortion continues even as the Senate fails again to muster the votes to write abortion rights into law. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KHNs Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
The unprecedented early leak of a Supreme Court draft opinion that would overturn the landmark abortion-rights ruling Roe v. Wade has heated the national abortion debate to boiling. Meanwhile, the FDA, after years of consideration, moves to ban menthol flavors in cigarettes and cigars. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Shefali Luthra of the 19th, and Jessie Hellmann of CQ Roll Call join KHNs Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHNs Paula Andalo, who wrote the latest KHN-NPR Bill of the Month episode about a family whose medical debt drove them to seek care south of the border.
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicares coverage decision for the controversial Alzheimers disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHNs Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
穢 2026 KFF